Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA Effect on Startle Response in Healthy Volunteers
NCT03181763Phase 1Completed
- Sponsor
- Lykos Therapeutics
- Start
- Mar 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by Lykos Therapeutics. Primary endpoint: Electromyography of right orbicularis oculi muscle at 4 days. Started Mar 2017; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03181763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181763.